These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 34519808

  • 1. Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    Gurkan UA.
    JAMA; 2021 Sep 14; 326(10):975. PubMed ID: 34519808
    [No Abstract] [Full Text] [Related]

  • 2. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT.
    JAMA; 2021 Apr 20; 325(15):1513-1523. PubMed ID: 33877274
    [Abstract] [Full Text] [Related]

  • 3. Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    Kenter MJH, Cohen AF.
    JAMA; 2021 Sep 14; 326(10):974-975. PubMed ID: 34519809
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM, Hoppe CC, Abboud MR, Inusa B, Kanter J, Ogutu B, Brown PB, Heath LE, Jakubowski JA, Zhou C, Zamoryakhin D, Agbenyega T, Colombatti R, Hassab HM, Nduba VN, Oyieko JN, Robitaille N, Segbefia CI, Rees DC, DOVE Investigators.
    N Engl J Med; 2016 Feb 18; 374(7):625-35. PubMed ID: 26644172
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC, Styles L, Heath LE, Zhou C, Jakubowski JA, Winters KJ, Brown PB, Rees DC, Heeney MM.
    Pediatr Blood Cancer; 2016 Feb 18; 63(2):299-305. PubMed ID: 26402148
    [Abstract] [Full Text] [Related]

  • 9. A holistic approach to vaso-occlusive pain crisis in children with sickle cell disease.
    Houser B, Plawecki HM, Carr J, Smith MA, Plawecki JA.
    J Holist Nurs; 1992 Mar 18; 10(1):62-75. PubMed ID: 1293205
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study.
    Conran N, de Alvarenga Maximo C, Oliveira T, Fertrin KY, Lobo C, Costa FF.
    Br J Haematol; 2022 Oct 18; 199(1):153-157. PubMed ID: 35834407
    [No Abstract] [Full Text] [Related]

  • 12. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N, Floroff C, Hassig TB, Boylan A, Kanter J.
    J Pain Palliat Care Pharmacother; 2018 Mar 18; 32(1):20-26. PubMed ID: 29791238
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients.
    Galeotti C, Courtois E, Carbajal R.
    Acta Paediatr; 2014 Dec 18; 103(12):e548-54. PubMed ID: 25130719
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Magnesium for treating sickle cell disease.
    Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L.
    Cochrane Database Syst Rev; 2017 Apr 14; 4(4):CD011358. PubMed ID: 28409830
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.